Funds for R&D in drug discovery and manufacturing :PIB

An outlay of Rs. 1,500 crore has been approved for strengthening/ up-gradation of these NIPERs for the period 2021-22 to 2025-26.

Mandaviya calls for collaboration to eliminate vector borne diseases

CEPI and Codiak BioSciences partner to develop protective Betacoronavirus vaccine

CEPI will provide seed funding of up to US$2.5 million to Codiak BioSciences.

Apollo Hospitals integrates cardiovascular risk tool with ConnectedLife digital wellness solutions

The AICVD tool can predict the risk of cardiovascular disease.

NITI Aayog releases a compendium of Ayush-based practices

The compendium was released by Suman Bery, Vice-Chairman, NITI Aayog and Dr. Munjpara Mahendrabhai Kalubhai, Minister of State for Ayush and WCD.

Takeda’s dengue vaccine candidate offers protection against dengue fever in clinical trial

TAK-003 is currently undergoing regulatory review for potential licensure in both the European Union

Tetra Bio-Pharma opens new subsidiary in Australia

The new subsidiary follows the recent announcement of Tetra's partnership with Cannvalate Pty Ltd for the performance of clinical trials of Tetra's drug candidates in Australia.

India is dedicated to ensure health Security for every citizen: Mandaviya

States have an important role in ensuring food safety and healthy food practices.

Cabinet approves MoU signed between India and USA in health sector

This MoU will further strengthen relations between India and the USA within the framework of international scientific and technological cooperation in fields of mutual interest.

India ready for playing global role to provide healthcare services: Mandaviya

India is at a key inflexion point of not just ‘Heal in India’ through its vibrant medical value tourism, but also ‘Heal by India’, where our medical professionals can be used to serve not just our country but at the global level.